Thailand’s much-anticipated coronavirus mass-vaccination campaign launched Monday. The campaign plans to primarily use COVID-19 vaccines locally produced by Siam BioScience, a royally owned pharmaceutical company, according to Al Jazeera.
The Thai government’s vaccination efforts have come under strong criticism, particularly because of its reliance on vaccines produced by Siam BioScience, a company owned by Thai royalty, reported The Associated Press.
What vaccines is Thailand using?
Oxford’s AstraZeneca has partnered with Thai pharmaceutical company Siam BioScience to produce vaccines. The partnership aims to produce and distribute more vaccines across Southeast Asia, CNN reported.
- Siam BioScience has no experience producing vaccines, said the AP.
- Skepticism has emerged about the production capabilities of Siam BioScience, per the AP.
However, the sole owner of Siam…
